secwatch.observer — SEC 8-K summary
======================================

Issuer:     Science 37 Holdings, Inc. (—)
CIK:        0001819113
Form:       8-K
Filed at:   2024-03-12T23:59:59+00:00
Accession:  0001104659-24-033266
Event type: m_and_a
Sentiment:  neutral
Materiality: 1.00
Item codes: 2.01, 3.01, 3.03, 5.01, 5.03, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Science 37 acquired by eMed in $38M all-cash deal; shares to be delisted from Nasdaq
--------------------------------------------------------------------------------

- eMed's Merger Sub completed tender offer at $5.75/share; 77.8% of shares tendered.
- Merger closed March 12, 2024; remaining shares converted to $5.75 per share cash.
- Aggregate consideration of ~$38M, funded from eMed's cash and short-term borrowing.
- All 7 directors resigned; Michael Cole and Jeffrey Schumm appointed as new board.
- Science 37 requested Nasdaq delisting and will file Form 15 to suspend SEC reporting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819113/000110465924033266/0001104659-24-033266-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819113/000110465924033266/tm244329d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-033266

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer